907 related articles for article (PubMed ID: 27744310)
1. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
3. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
[TBL] [Abstract][Full Text] [Related]
4. Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays.
Guegan H; Robert-Gangneux F; Camus C; Belaz S; Marchand T; Baldeyrou M; Gangneux JP
J Infect; 2018 Feb; 76(2):196-205. PubMed ID: 29248586
[TBL] [Abstract][Full Text] [Related]
5. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
Eigl S; Prattes J; Reinwald M; Thornton CR; Reischies F; Spiess B; Neumeister P; Zollner-Schwetz I; Raggam RB; Flick H; Buchheidt D; Krause R; Hoenigl M
Int J Antimicrob Agents; 2015 Oct; 46(4):401-5. PubMed ID: 26187363
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Novel
Dichtl K; Seybold U; Ormanns S; Horns H; Wagener J
J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018980
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
9. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single-centre study.
Serin I; Dogu MH
Mycoses; 2021 Jun; 64(6):678-683. PubMed ID: 33683715
[TBL] [Abstract][Full Text] [Related]
10. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.
Wehrle-Wieland E; Affolter K; Goldenberger D; Tschudin Sutter S; Halter J; Passweg J; Tamm M; Khanna N; Stolz D
Transpl Infect Dis; 2018 Oct; 20(5):e12953. PubMed ID: 29896857
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
[TBL] [Abstract][Full Text] [Related]
15. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
[TBL] [Abstract][Full Text] [Related]
16. Use of Galactomannan Antigen and Aspergillus DNA Real-time Polymerase Chain Reaction as Routine Methods for Invasive Aspergillosis in Immunosuppressed Children in Greece.
Vrioni G; Theodoridou K; Tsiamis C; Mavrouli M; Kapsimali V; Rigopoulos D; Tsakris A
Clin Ther; 2018 Jun; 40(6):918-924.e2. PubMed ID: 29807668
[TBL] [Abstract][Full Text] [Related]
17. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
[TBL] [Abstract][Full Text] [Related]
18. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
[TBL] [Abstract][Full Text] [Related]
19. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the lateral flow Aspergillus assay for the diagnosis of invasive aspergillosis, experience in a university hospital].
Delama I; Legarraga P; González T; García P; Rabagliati R
Rev Chilena Infectol; 2018; 35(5):574-579. PubMed ID: 30725006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
